Patient Data Which other medications might be helpful for this client in his management of asthma? Select all that apply.

A. Antiproliferative agents: These are primarily used in conditions like organ transplantation and autoimmune diseases to suppress cell growth. They are not indicated for the management of asthma and would not benefit the client’s respiratory symptoms. B. Biologics: Biologics such as omalizumab (anti-IgE) or mepolizumab (anti-IL-5) are used in moderate to severe asthma cases that are not well controlled with inhaled therapies. They target specific pathways in the inflammatory process and can help reduce exacerbations in allergic or eosinophilic asthma. C. Loop diuretic: Loop diuretics like furosemide are used to manage fluid overload in conditions like heart failure, not for airway inflammation or bronchospasm in asthma. They have no direct role in asthma management. D. Glucocorticoids: Inhaled or systemic glucocorticoids are essential in controlling airway inflammation and preventing exacerbations in asthma. They are a cornerstone of asthma management, especially if frequent rescue inhaler use is noted. E. Long-acting beta agonists (LABAs): LABAs like salmeterol or formoterol are used in combination with inhaled corticosteroids for maintenance therapy in moderate to severe asthma. They help provide sustained bronchodilation but are not used alone due to increased risk of asthma-related death if unpaired with a steroid. F. Angiotensin-converting enzyme (ACE) inhibitor: ACE inhibitors are primarily used for hypertension and heart failure. They are not asthma treatments and can sometimes worsen coughing, which could complicate asthma symptoms.